Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer

Clinical trial NCT04984096 · UNKNOWN

Trial details

NCT number: NCT04984096
Sponsor: Shanghai Chest Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Esophageal Cancer

Start date: 2021-08-01
Primary completion: 2021-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.